126 related articles for article (PubMed ID: 6434769)
21. Pituitary dwarfism in a patient with circulating abnormal growth hormone polymers.
Valenta LJ; Sigel MB; Lesniak MA; Elias AN; Lewis UJ; Friesen HG; Kershnar AK
N Engl J Med; 1985 Jan; 312(4):214-7. PubMed ID: 3965948
[No Abstract] [Full Text] [Related]
22. The role of insulin, glucagon and growth hormone in the regulation of plasma glucose and free fatty acid levels in anorexia nervosa.
Blickle JF; Reville P; Stephan F; Meyer P; Demangeat C; Sapin R
Horm Metab Res; 1984 Jul; 16(7):336-40. PubMed ID: 6386641
[TBL] [Abstract][Full Text] [Related]
23. Stimulation tests of human growth hormone secretion by insulin, lysine vasopressin, pyrogen and glucagon.
Ogawa N
Acta Med Okayama; 1974 Jun; 28(3):181-97. PubMed ID: 4280230
[No Abstract] [Full Text] [Related]
24. [Behavior of the somatotropic hormone and of somatomedin (sulfation factor) in achondroplasia].
Isidori A; Cianfriglia F; Dondero F
Folia Endocrinol; 1974 Apr; 27(2):179-84. PubMed ID: 4406489
[No Abstract] [Full Text] [Related]
25. Growth hormone and prolactin response to growth hormone-releasing in anorexia nervosa.
Lomeo A; Mazzocchi G; Sessarego P; Torre R; Delmonte P; Giusti M
Recenti Prog Med; 1989 Nov; 80(11):569-73. PubMed ID: 2516349
[TBL] [Abstract][Full Text] [Related]
26. Effect of growth hormone-releasing factor on growth hormone release in children with radiation-induced growth hormone deficiency.
Lustig RH; Schriock EA; Kaplan SL; Grumbach MM
Pediatrics; 1985 Aug; 76(2):274-9. PubMed ID: 3927254
[TBL] [Abstract][Full Text] [Related]
27. Effects of beta-adrenergic agonists and antagonists on the growth hormone response to growth hormone-releasing hormone in anorexia nervosa.
Gianotti L; Arvat E; Valetto MR; Ramunni J; Di Vito L; Maccagno B; Camanni F; Ghigo E
Biol Psychiatry; 1998 Feb; 43(3):181-7. PubMed ID: 9494699
[TBL] [Abstract][Full Text] [Related]
28. [The content of somatotropic hormone, inorganic phosphorus and nonesterified fatty acids in the blood serum of patients with acromegaly in various therapeutic effects].
Balabolkin MI
Probl Endokrinol Gormonoter; 1966; 12(2):40-4. PubMed ID: 6002141
[No Abstract] [Full Text] [Related]
29. Preliminary studies of plasma growth hormone releasing activity during medical therapy of acromegaly.
Hagen TC; Lawrence AM; Kirsteins L
Horm Metab Res; 1978 Jul; 10(4):310-3. PubMed ID: 98420
[TBL] [Abstract][Full Text] [Related]
30. "Paradoxical" GH suppression by secretagogues in acromegaly?
Ohashi S; Kaji H; Abe H; Chihara K
Horm Metab Res; 1993 Jul; 25(7):393-4. PubMed ID: 8406329
[No Abstract] [Full Text] [Related]
31. [Radioimmunoassay of human growth hormone].
Irie M; Sakuma M
Nihon Naibunpi Gakkai Zasshi; 1966 Aug; 42(5):475-88. PubMed ID: 6007896
[No Abstract] [Full Text] [Related]
32. Clinical experience with human growth hormone immunoassay by a two-antibody method.
Ewer RW; Deiss WP
Arch Intern Med; 1969 Oct; 124(4):461-7. PubMed ID: 4309856
[No Abstract] [Full Text] [Related]
33. Effect of growth hormone-releasing factor on the response to insulin of cows during early and late lactation.
Rose MT; Obara Y; Fuse H; Itoh F; Ozawa A; Takahashi Y; Hodate K; Ohashi S
J Dairy Sci; 1996 Oct; 79(10):1734-45. PubMed ID: 8923244
[TBL] [Abstract][Full Text] [Related]
34. Genetic pituitary dwarfism with high serum concentation of growth hormone--a new inborn error of metabolism?
Laron Z; Pertzelan A; Mannheimer S
Isr J Med Sci; 1966; 2(2):152-5. PubMed ID: 5916640
[No Abstract] [Full Text] [Related]
35. [Behavior of somatotropinemia and insulinemia in some forms of short stature].
Liuzzi A; Chiodini PG; Cremoncini C; Botalla L; Spinelli F
Folia Endocrinol; 1969 Dec; 22(4):373-91. PubMed ID: 5409261
[No Abstract] [Full Text] [Related]
36. Galactopoietic effects of recombinant somatotropin and growth hormone-releasing factor in dairy cows.
Dahl GE; Chapin LT; Moseley WM; Tucker HA
J Dairy Sci; 1993 Jun; 76(6):1550-7. PubMed ID: 8326029
[TBL] [Abstract][Full Text] [Related]
37. Pituitary dwarfism with high serum levels of growth hormone.
Laron Z; Pertzelan A; Karp M
Isr J Med Sci; 1968; 4(4):883-94. PubMed ID: 5707788
[No Abstract] [Full Text] [Related]
38. [Growth hormone releasing hormone. Review].
Rosskamp R
Klin Padiatr; 1988; 200(2):81-8. PubMed ID: 3133522
[TBL] [Abstract][Full Text] [Related]
39. Value of growth hormone dynamics and somatomedin C (insulin-like growth factor I) levels in predicting the long-term benefit after transsphenoidal surgery for acromegaly.
Arafah BM; Rosenzweig JL; Fenstermaker R; Salazar R; McBride CE; Selman W
J Lab Clin Med; 1987 Mar; 109(3):346-54. PubMed ID: 3102658
[TBL] [Abstract][Full Text] [Related]
40. [Glucose consumption and free fatty acid changes in plasma in hypothalamo-hypophyseal dwarfism and in children with familial short stature].
Rybakowa M; Dropowa K; Krop J; Lawecki J
Pediatr Pol; 1973 Mar; 48(3):279-84. PubMed ID: 4693961
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
